ILMN Jan 2025 95.000 call
| Previous close | 113.75 |
| Open | 113.75 |
| Bid | 119.00 |
| Ask | 126.50 |
| Strike | 95.00 |
| Expiry date | 2025-01-17 |
| Day's range | 113.75 - 113.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
- Bloomberg
Illumina, Icahn Fight Intensifies After Negotiation Failed
(Bloomberg) -- Illumina Inc. and activist investor Carl Icahn tried but failed to reach a compromise that would have avoided the public battle over seats on its board, according to a preliminary proxy statement filed by the DNA-sequencing company.Most Read from BloombergTrump Faces Fingerprints, Mug Shot After Dramatic IndictmentSingapore’s Changi Sees Immigration System Restored After Delays$335,000 Pay for ‘AI Whisperer’ Jobs Appears in Red-Hot MarketA $3 Trillion Threat to Global Financial Ma
- Financial Times
Illumina chief’s pay nearly doubles ahead of clash with Carl Icahn
Francis deSouza was awarded $26.7mn in total pay last year despite drop in genome sequencer’s market value
- Zacks
Illumina (ILMN) to Enable Tertiary Analysis With New Launch
Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.
